MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
Open | $5.76 |
Close | - |
Volume / Avg. | 868.08K / 2.35M |
Day Range | 5.72 - 5.84 |
52 Wk Range | 3.17 - 6.04 |
Market Cap | $1.57B |
P/E Ratio | 142.75 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 12.75% |
Days to Cover | 10.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Other companies in MannKind’s space includes: Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), Immatics (NASDAQ:IMTX), Day One Biopharmaceutical (NASDAQ:DAWN) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
There is no analysis for MannKind.
MannKind has a consensus price target of $7.60.
The stock price for MannKind (NASDAQ: MNKD) is $5.795 last updated Today at July 22, 2024 at 12:45 PM EDT.
There are no upcoming dividends for MannKind.
MannKind’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.